Sartorius Aktiengesellschaft (ETR:SRT3)

Market Cap	14.73B -5.0%
Revenue (ttm)	3.52B +5.8%
Net Income	133.60M +72.2%
EPS	n/a
Shares Out	69.04M
PE Ratio	110.29
Forward PE	65.39
Dividend	0.74 (0.31%)
Ex-Dividend Date	Mar 27, 2026

Volume	94,094
Average Volume	98,102
Open	240.20
Previous Close	241.80
Day's Range	234.60 - 242.20
52-Week Range	166.05 - 267.70
Beta	1.52
RSI	42.85
Earnings Date	Feb 3, 2026

About ETR:SRT3

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cy...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1870
• Employees: 13,878
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: SRT3

Financial Performance

In 2024, ETR:SRT3's revenue was 3.38 billion, a decrease of -0.44% compared to the previous year's 3.40 billion. Earnings were 84.00 million, a decrease of -59.14%.